Assenagon Asset Management
TIL icon

Assenagon Asset Management’s Instil Bio TIL Stock Holding History

Assenagon Asset Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-57,497
Closed -$1.2M – 1266
2025
Q2 		$1.2M Buy
57,497
+4,400
+8% +$92K ﹤0.01% 887
2025
Q1 		$922K Sell
53,097
-9,461
-15% -$196K ﹤0.01% 919
2024
Q4 		$1.19M Buy
+62,558
New +$1.91M ﹤0.01% 1070
2023
Q4 		– Sell
-1,493
Closed -$12.8K – 1489
2023
Q3 		$12.8K Sell
1,493
-2,977
-67% -$30K ﹤0.01% 1369
2023
Q2 		$49.3K Sell
4,470
-2,494
-36% -$30.5K ﹤0.01% 1308
2023
Q1 		$92K Buy
+6,964
New +$103K ﹤0.01% 1386

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management's TIL Position: Q3 2025 in Review

Assenagon Asset Management sold out of Instil Bio (TIL) in Q3 2025, closing a stake of 57,497 shares — an estimated $1.2M sold.

Assenagon Asset Management first reported a position in TIL in Q1 2023 and held it in 6 quarters. The position peaked at $1.2M in Q2 2025. 34 funds tracked by Wall St. Rank hold TIL as of Q3 2025.

  • Assenagon Asset Management reported no remaining Instil Bio position as of Q3 2025 after selling out during the quarter.
  • Assenagon Asset Management sold 57,497 Instil Bio shares in Q3 2025, an estimated $1.2M.
  • Assenagon Asset Management first reported a position in Instil Bio in Q1 2023 and held it in 6 quarters.
  • Assenagon Asset Management's Instil Bio position peaked at $1.2M in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Instil Bio as of Q3 2025.

Based on Assenagon Asset Management's 13F filing for Q3 2025, filed 7 Oct 2025.